Back to top
more

Sensus Healthcare (SRTS)

(Delayed Data from NSDQ)

$5.25 USD

5.25
106,972

-0.25 (-4.55%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $5.21 -0.04 (-0.76%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Best Momentum Stocks to Buy for December 17th

by Zacks Equity Research

EXPD, FORR, BLDR, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 17, 2021.

Nilanjan Banerjee headshot

Sail Through the Choppy Market With These 3 Low-Beta Stocks

by Nilanjan Banerjee

It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. Amphastar (AMPH), Sanderson Farms (SAFM) and Sensus Healthcare (SRTS) are well poised to gain.

Zacks Equity Research

Best Momentum Stocks to Buy for December 15th

by Zacks Equity Research

GES, AOSL, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 15, 2021.

Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

What Makes Sensus Healthcare, Inc. (SRTS) a Good Fit for "Trend Investing"

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

Zacks.com featured highlights include: Sensus Healthcare, Dorman Products and Sociedad Quimica y Minera

by Zacks Equity Research

Zacks.com featured highlights include: Sensus Healthcare, Dorman Products and Sociedad Quimica y Minera

Tirthankar Chakraborty headshot

3 Best Stocks to Invest In for Superb Earnings Acceleration

by Tirthankar Chakraborty

Sensus Healthcare (SRTS), Dorman Products (DORM) & Sociedad Quimica y Minera (SQM) at present flaunt solid earnings acceleration. This calls for investing in them right away.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Build-A-Bear, REX American Resources, Medallion Financial, First Community and Sensus Healthcare

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Build-A-Bear, REX American Resources, Medallion Financial, First Community and Sensus Healthcare

Zacks Equity Research

Wall Street Analysts Believe Sensus Healthcare, Inc. (SRTS) Could Rally 27%: Here's is How to Trade

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 26.8% in Sensus Healthcare, Inc. (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nalak Das headshot

Top 5 Small Caps Flying High Defying Omicron-Led Turmoil

by Nalak Das

We have narrowed our search to five small cap stocks that have surged since the Thanksgiving Day. These are: BBW, FCCO, REX, MFIN and SRTS.

Nilanjan Banerjee headshot

Bet on These 3 Low-Beta Stocks to Combat Market Volatility

by Nilanjan Banerjee

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Amphastar Pharmaceuticals (AMPH), AMN Healthcare (AMN) & Sensus Healthcare (SRTS) are well poised to gain.

Zacks Equity Research

Best Momentum Stocks to Buy for November 30th

by Zacks Equity Research

VSTO, SRTS, PLCE, and NMRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 30, 2021.

Zacks Equity Research

Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Zacks.com featured highlights include: Dave & Buster's Entertainment, Sensus Healthcare and Sociedad Quimica y Minera de Chile

by Zacks Equity Research

Zacks.com featured highlights include: Dave & Buster's Entertainment, Sensus Healthcare and Sociedad Quimica y Minera de Chile

Tirthankar Chakraborty headshot

3 Top-Ranked Stocks to Buy for Solid Earnings Acceleration

by Tirthankar Chakraborty

Dave & Buster's (PLAY), Sensus Healthcare (SRTS) & Sociedad Quimica y Minera (SQM) are worth buying now for superb earnings acceleration.

Zacks Equity Research

After Golden Cross, Sensus Healthcare, Inc. (SRTS)'s Technical Outlook is Bright

by Zacks Equity Research

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 200.00% and 2.70%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Sensus Healthcare, Inc. (SRTS) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 60.00% and 33.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Sensus Healthcare, Inc. (SRTS) Report Negative Q2 Earnings? What You Should Know

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 22.22% and -22.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

by Zacks Equity Research

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.